Downregulation of miR-195-5p inhibits endothelial-mesenchymal transition and myocardial fibrosis in diabetic cardiomyopathy by targeting Smad7 and the TGF-β1/Smads/Snail pathway [128]. This evidence concerns the gene SMAD7 and Myocardial fibrosis.